Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ATAC sequence analysis to compare MMTV-PyMT tumor cells with and without Dll1

ABSTRACT: Several genes like Nfkb, Npy and Dll1 showed altered enrichment peaks between Dll1+ and Dll1- population of tumor cells.

ORGANISM(S): Mus musculus

PROVIDER: GSE133736 | GEO | 2020/11/20

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA sequence analysis to compare MMTV-PyMT tumor cells with and without Dll1

Project description:Several cell cycle genes were altered between Dll1+ and Dll1- population of tumor cells

2020-11-20 | GSE129198 | GEO

ATAC sequence analysis to compare MMTV-PyMT tumor cells with and without Dll1

Project description:ATAC sequence analysis to compare MMTV-PyMT tumor cells with and without Dll1

| PRJNA552361 | ENA

RNA sequence analysis to compare MMTV-PyMT tumor cells with and without Dll1

Project description:RNA sequence analysis to compare MMTV-PyMT tumor cells with and without Dll1

| PRJNA530514 | ENA

RNA sequence analysis to compare MCF7 Tamoxifen resistant cells with and without DLL1

Project description:Several signatures including Tgb pathway, cytokines, Notch signaling is altered whe DLL1 is reduced

2023-01-20 | GSE143989 | GEO

RNA sequence analysis to compare Dll1+ mouse breast tumor cells with and without targeted radiation

Project description:Data generrated shows that Dll1 has several genes upregulated after targeted radiation at day 30 inlcuding EMT, ROS etc

2022-04-20 | GSE172398 | GEO

RNA sequence analysis to compare MCF7 Tamoxifen resistant cells with and without DLL1

Project description:RNA sequence analysis to compare MCF7 Tamoxifen resistant cells with and without DLL1

| PRJNA602464 | ENA

RNA sequence analysis to compare Dll1+ mouse breast tumor cells with and without targeted radiation

Project description:RNA sequence analysis to compare Dll1+ mouse breast tumor cells with and without targeted radiation

| PRJNA723221 | ENA

Activity of the mouse Notch ligand DLL1 is sensitive to C-terminal tagging in vivo

Project description:Objective DLL1 is a mammalian Notch ligand with essential functions during embryonic development. We tagged endogenous DLL1 in one homologous recombination step such that AcGFP-HA tagged DLL1 could be converted by Cre-mediated site-specific recombination into StrepFlag tagged DLL1. We anticipated that this should allow us to visualise DLL1 in living cells as well as allow for sorting and enrichment of DLL1-expressing cells and efficient purification of DLL1 protein complex. Results We generated constructs to express a DLL1 variant that carried C-terminal in frame an AcGFPHA tag flanked by loxP sites followed by a StrepFlag tag out of frame. Cre-mediated recombination removed AcGFP-HA and added StrepFlag in frame to DLL1. The AcGFPHAstopStrepFlag tag was added to the Dll1 cDNA to allow for tests in cultured cells in vitro and was introduced into endogenous DLL1 in mice using ES cells modified by homologous recombination. Tagged DLL1 protein was detected by antibodies against GFP and HA or Flag, respectively, both in CHO cell and embryo lysates. In CHO cells the AcGFP protein fused to DLL1 was functional. In vivo AcGFP expression was below the level of detection by direct fluorescence. However, the StrepFlag tag allowed us to specifically purify DLL1 complexes from embryo lysates. Homozygous mice expressing AcGFPHA or StrepFlag-tagged DLL1 revealed a vertebral column phenotype reminiscent of disturbances in AP polarity during somitogenesis, a process most sensitive to reduced DLL1 function. Thus, even small C-terminal tags can impinge on sensitive developmental processes requiring DLL1 activity.

2021-11-03 | PXD024680 | Pride

Immunosurveillance and immunoediting in MMTV-PyMT-induced mammary oncogenesis.

Project description:Evidence of cancer immunosurveillance and immunoediting processes has been primarily demonstrated in mouse models of chemically induced oncogenesis. Although these models are very tractable, they are characterized by high mutational loads that represent a minority of human cancers. In this study, we sought to determine whether cancer immunosurveillance and immunoediting could be demonstrated in a more clinically relevant oncogene-induced model of carcinogenesis, the MMTV-PyMT (PyMT) mammary carcinoma model. This model system in the FVB/NJ strain background was previously used to demonstrate that adaptive immunity had no role in limiting primary cancer formation and in fact promoted metastasis, thus calling into question whether cancer immunosurveillance operated in preventing the development of breast cancer. Our current study in the C57BL/6 strain backgrounds provides a different conclusion, as we report here the existence of an adaptive immunosurveillance of PyMT mammary carcinomas using two independent models of immune deficiency. PyMT mice bred onto a Rag1-/- background or immune suppressed by chronic tacrolimus therapy both demonstrated accelerated development of mammary carcinomas. By generating a bank of cell lines from these animals, we further show that a subset of PyMT cell lines had delayed growth after transplantation into wild-type (WT) syngeneic, but not immune-deficient hosts. This reduced growth rate in immunocompetent animals was characterized by an increase in immune cell infiltration and tissue differentiation. Furthermore, loss of the immune cell infiltration that characterized immunoediting of slow growing cell lines, changed them into fast growing variants capable of progressing in the immunocompetent model. In conclusion, our study provides evidence that immunosurveillance and immunoediting of PyMT-derived cell lines modulate tumor progression in this oncogene-induced model of cancer.

| S-EPMC5353915 | biostudies-literature

Dll1 dependent heterogeneity of tumor and cancer fibroblasts

Project description:To survey the diverse tumor cell populations of aggressive luminal breast cancer (non-TNBC) at a cellular level, we utilized Dll1+ and Dll1- tumors from a recently published PyMT-Dll1mCherry reporter breast cancer mouse model.

2022-08-14 | GSE182011 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data